CircRNA vaccine encoding a chimeric immunogen of B6 and M1 demonstrates robust immune responses against MPXV

vaccine confers complete protection to immunized mice against the lethal VACV challenge. Collectively, these findings identify promising immunogen candidates for developing next-generation circRNA vaccines against the MPXV and other orthopoxviruses.